SCHEMBL181848

SCHEMBL181848

CC(C)(C)OC(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 7/20 0.65
PPARG P37231 6/20 0.65
ACE P12821 1/20 0.62
ITGB3 P05106 2/20 0.62
ITGA2B P08514 2/20 0.62
CTSS P25774 6/20 0.56
CTSK P43235 5/20 0.56
CTSL P07711 2/20 0.55
CTSB P07858 1/20 0.55
ITGA4 P13612 1/20 0.53
ITGB7 P26010 1/20 0.53
PTPN1 P18031 2/20 0.53
PPARD Q03181 2/20 0.52
ITGB1 P05556 1/20 0.52
ITGAV P06756 1/20 0.52
ITGB5 P18084 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1309909 1.00 PPARA (0.65) PPARAPPARGACEITGB3ITGA2B
SCHEMBL181849 1.00 PPARA (0.65) PPARAPPARGACEITGB3ITGA2B
SCHEMBL3722240 0.96 PPARA (0.61) PPARAPPARGACEITGB3ITGA2B
SCHEMBL22009950 0.96 PPARA (0.61) PPARAPPARGACEITGB3ITGA2B
SCHEMBL3722245 0.96 PPARA (0.61) PPARAPPARGACEITGB3ITGA2B
SCHEMBL2290585 0.94 ITGB3 (0.62) PPARAPPARGACEITGB3ITGA2B
SCHEMBL2290589 0.94 ITGB3 (0.62) PPARAPPARGACEITGB3ITGA2B
SCHEMBL2287582 0.91 ITGB3 (0.59) PPARAPPARGACEITGB3ITGA2B
SCHEMBL2287578 0.91 ITGB3 (0.59) PPARAPPARGACEITGB3ITGA2B
SCHEMBL7481627 0.89 PPARG (0.59) PPARAPPARGACEITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104910046-B Phenylacetylene derivative with double chiral carbon atoms on pendant group and preparation method and application thereof 哈尔滨工程大学 2017-05-24 CN claimed
CN-104910039-A Functional phenylacetylene compound and preparation method thereof UNIV HARBIN ENG 2015-09-16 CN claimed
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2012-02-16 US claimed
EP-1981831-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF Vaidya, Niteen A. (US) 2008-10-22 EP claimed
WO-2007092264-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2007-08-16 WO claimed
US-20070185346-A1 Kit for automated resolving agent selection and method thereof VAIDYA NITEEN A 2007-08-09 US claimed
EP-4702033-A1 DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF Imhotex Limited (GB) 2026-03-04 EP disclosed
US-20260001924-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME NEW YORK UNIVERSITY (US) 2026-01-01 US disclosed
US-12486302-B2 Somatostatin receptor antagonist compounds and methods of using the same CDRD VENTURES INC. (CA) 2025-12-02 US disclosed
US-12404265-B2 Substituted pyridine derivatives as SARM1 inhibitors NURA BIO, INC. (US) 2025-09-02 US disclosed
US-12371461-B2 Nemo coiled coil mimics and methods of using same NEW YORK UNIVERSITY (US) 2025-07-29 US disclosed
US-12371406-B2 Dual acting FKBP12 and FKBP52 inhibitors PLEX PHARMACEUTICALS, INC. (US) 2025-07-29 US disclosed
EP-4269400-B1 YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS MOLECURE SA (PL) 2025-07-09 EP disclosed
EP-0215171-A2 Peptides THE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND (US) 1987-03-25 EP disclosed
EP-0081877-B1 LH-RH ANTAGONISTS COY, David Howard (US) 1986-04-30 EP disclosed
EP-0041286-B1 LH-RH ANTAGONISTS Schally, Andrew Victor (US) 1984-08-15 EP disclosed
US-4431635-A PEPTIDE ANALOGS OF LUTEINIZING HORMONE RELEASING HORMONE; GLANDULAR DISORDERS; ANTICARCINOGENIC AGENTS COY DAVID HOWARD 1984-02-14 US disclosed
EP-0081877-A1 LH-RH antagonists COY, David Howard (US) 1983-06-22 EP disclosed
US-4317815-A PEPTIDE ANALOGS OF LUTENIZING HORMONE RELEASING HORMONE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND, THE, A CORPORATE ENTITY OF TULANE UNIVERSITY A CORP. OF LA. 1982-03-02 US disclosed
EP-0041286-A1 LH-RH antagonists Schally, Andrew Victor (US) 1981-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12404265-B2 Substituted pyridine derivatives as SARM1 inhibitors SARM1, SARNP, ADRM1 PPARA 3678/4885PPARG 2613/4885ACE 1597/4885
US-12371461-B2 Nemo coiled coil mimics and methods of using same COIL, CALCOCO2, NCAPH PPARA 4497/4885PPARG 4002/4885ACE 4652/4885
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF ACKR3, KIT, C3AR1 PPARA 3818/4885PPARG 4330/4885ACE 140/4885
US-12486302-B2 Somatostatin receptor antagonist compounds and methods of using the same GPR119, SSTR5, SSTR2 PPARA 798/4885PPARG 729/4885ACE 839/4885
US-20260001924-A1 NEMO COILED COIL MIMICS AND METHODS OF USING SAME DDX21, PHAX, RBX1 PPARA 3778/4885PPARG 3003/4885ACE 4863/4885
US-12371406-B2 Dual acting FKBP12 and FKBP52 inhibitors FKBP2, FKBP1B, FKBP1A PPARA 1968/4885PPARG 1485/4885ACE 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.